Alimera Sciences Inc (NASDAQ:ALIM)

1.28
Delayed Data
As of Feb 23
 +0.03 / +2.40%
Today’s Change
1.03
Today|||52-Week Range
1.72
-3.76%
Year-to-Date
No recent news for Alimera Sciences Inc.

Today’s Trading

Previous close1.25
Today’s open1.26
Day’s range1.21 - 1.28
Volume117,959
Average volume (3 months)158,616
Market cap$88.5M
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+8.70%
Earnings growth (this year)+58.33%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+53.01%
P/E ratioNM
Price/Sales1.66
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MEIPMEI Pharma Inc-0.01-0.46%
SYNSynthetic Biologics ...-0.01-2.64%
VVUSVIVUS Inc-0.01-1.81%
ZFGNZafgen Inc+0.25+3.22%
Data as of 8:00pm ET, 02/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$34.3M
Annual profit (last year)-$33.2M
Net profit margin-96.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Charles Daniel Myers
President &
Chief Financial Officer
Richard S. Eiswirth
Corporate headquarters
Alpharetta, Georgia

Forecasts